v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net loss $ (5,210) $ (13,453)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,329 1,033
Stock-based compensation 16,497 17,940
Non-cash operating lease cost 2,027 1,917
Net loss on sale of available-for-sale securities 5 5
Unrealized gain on investments (46) (198)
Non-cash interest expense 282 298
Foreign currency remeasurement (gain) loss (108) 147
Changes in operating assets and liabilities:    
Accounts receivable (398) 212
Inventories (9,624) (11,506)
Prepaid and other assets 844 (2,069)
Accounts payable (1,881) 3,362
Accrued liabilities and other non-current liabilities (6,579) 66
Deferred revenue 159 883
Net cash used in operating activities (2,703) (1,363)
Investing activities    
Capital expenditures (1,696) (2,422)
Purchases of investments (24,175) (27,765)
Proceeds from maturities and sale of investments 45,189 25,400
Net cash provided by (used in) investing activities 19,318 (4,787)
Financing activities    
Net proceeds from equity incentives 611 595
Net costs from public offerings (55) (35)
Net proceeds from revolving line of credit 9,536 702
Payments on loans (30,000)  
Debt issuance costs (166)  
Net cash (used in) provided by financing activities (20,074) 1,262
Effect of exchange rates on cash, cash equivalents, and restricted cash (166) 336
Net decrease in cash, cash equivalents, and restricted cash (3,625) (4,552)
Cash, cash equivalents, and restricted cash, beginning of period 20,600 21,361
Cash, cash equivalents, and restricted cash, end of period $ 16,975 $ 16,809